Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages


Articles: Drug Trials



Latest (2) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Trials, 06/05/09    Free full text
Sponsor
Inadequate planning and reporting of adjudication committees in clinical trials: Recommendation proposal
Journal of Clinical Epidemiology, 06/05/09
The evidence provided by a single trial is less reliable than its statistical analysis suggests
Journal of Clinical Epidemiology, 06/05/09
AstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances
AstraZeneca, 06/04/09    Free full text
New Findings Demonstrate Potential Benefits of GATTEX(TM) (teduglutide) in Phase 3 Study of Patients with Short Bowel Syndrome
NPS Pharmaceuticals, 06/04/09    Free full text
Making trials matter: pragmatic and explanatory trials and the problem of applicability
Trials, 06/04/09    Free full text
Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I-III Clinical Trials
PLoS Medicine, 06/04/09    Free full text
Multiple-blind: Towards a new blinding protocol for future generations of clinical trials
Medical Hypotheses, 06/04/09
Impact study showed longer valcyte (valganciclovir hydrochloride tablets) treatment demonstrated better protection against cytomegalovirus (cmv) disease one year post-transplant
Roche, 06/04/09    Free full text
Paclitaxel Poliglumex (OPAXIO) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
Cell Therapeutics, 06/04/09    Free full text
One-year Phase III study confirms Ilaris offers long-term remission in patients with CAPS, a severe lifelong auto-inflammatory disease
Novartis, 06/04/09    Free full text
Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment
Cell Therapeutics, 06/03/09    Free full text
Cytokinetics Presents Clinical Data Relating To Ispinesib in Patients with Metastatic Breast Cancer at the 2009 Annual Meeting of the American Society of Clinical Oncology
Cytokinetics, 06/03/09    Free full text
Assumes Primary Responsibility for Alemtuzumab in Multiple Sclerosis; Expands Hematologic Oncology Portfolio
Genzyme, 06/03/09    Free full text
GSKs Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer
GlaxoSmithKline, 06/02/09    Free full text
Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial
Active Biotech, 06/02/09    Free full text
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Onyx Pharmaceuticals, 06/02/09    Free full text
Positive Results from Salix Pivotal Phase III Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE) Presented at Digestive Disease Week
Salix Pharmaceuticals, 06/02/09    Free full text
VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients: A randomized, placebo-controlled study to evaluate the post-transplant outcome
Trials, 06/01/09    Free full text
Calcimimetics: A Review of the Recent Literature
Kidney, 06/01/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    19      20      21      22      23      24      25      26      27      28      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.